Podcasts about oncology pharmacy

In anticipation of the 51st Annual Meeting and Cancer Center Business Summit (AMCCBS), ACCCBuzz spoke with this year's keynote speaker, Nick Webb, who gave some insight into what AMCCBS attendees can expect from his session. As a health care futurist, Nick's consulting practice is centered around the future of health care and trends that are both already present and fast-approaching. One trend Nick plans to speak to in his keynote is hyper-consumerism and how it is impacting patients' experience with health care. Namely, patients today want customization, transparency, and humanity—among other things. They want relationships that are more than just the transaction of health care. Nick will dive into best practices to create experiential value for patients, as well as ways to leverage technological innovations like artificial intelligence to take the pressure off providers and free up their time so they can engage and create meaningful relationships with patients.  Guest:   Nick Webb Health Care Futurist Author, Chaotic Change: Embracing Chaos to Drive Innovation and Growth  Quote:   “[Patients today] want humanity. They want the relationship to be more than just the transaction of health care. The best organizations...are going to make the transition from the transaction of health care to the experiential value of health care.”  Register for the 51st AMCCBS and view the full agenda on the ACCC website.   Additional Resources:   ePROs: Lighting the Way to Improved Outcomes Efficiency and Patient Experience -- Oncology Issues   The Future of the Patient Experience — [MINI PODCAST] EP 137  Healthcare Burnout: An Epidemic Among Oncology Nurses  A Toxic Mixture: Burnout in Oncology Pharmacy  2024 Trending Now in Cancer Care Part 2 – Oncology Issues 

Jolynn Sessions, PharmD, CPP, BCOP, FHOPA, serves as President of the Hematology/Oncology Pharmacy Association (HOPA). She is an EXCLAIM Pharmacogenomics Pharmacist and an Oncology Clinical Pharmacist Specialist at the Western North Carolina VA Health Care System in Asheville, NC. We talk through her top three priorities for HOPA this year. You'll hear the top issues in oncology pharmacy and how HOPA is finding ways to solve them!

On this week's episode of The PQI Podcast, we sit down with Juline George, PharmD, and Sasha Watson, PharmD, to explore the significance of pharmacist collaboration in oncology and its impact on optimizing patient care.Discover how their partnership benefits patients, hear real-life examples of its positive impact, and gain valuable insights for fostering effective collaboration between medically integrated and specialty pharmacies in oncology care.Juline is a pharmacist specializing in complex drug therapy regimens within specialty disease states, including oncology, transplant, inflammatory conditions, and infectious disease with Walgreens Specialty Pharmacy.Sasha is an Outpatient Medical Oncology Clinical Pharmacist at the University of Miami Sylvester Comprehensive Cancer Center. She currently works with the GI and Sarcoma clinics at Sylvester.

In this week's episode of The PQI Podcast, we welcome Claire Kennedy, BSc (Hons), MAPharmT, and Chandra Maraj, BSc (Hons), MAPharmT, from Oxford University Hospitals NHS Foundation Trust. Joined by guest co-host Taryn Newsome, CPhT, Associate Manager of OPTA at NCODA, we dive into an engaging discussion on the evolving role of oncology pharmacy technicians in England.Claire, an Advanced Clinical Cancer Pharmacy Technician and Operational Manager, and Chandra, also an Advanced Clinical Cancer Pharmacy Technician and Cancer Pharmacy Manager at the same trust, are dedicated professionals passionate about advancing the career path and clinical role of Pharmacy Technicians in oncology.Chandra Maraj has devoted 14 years to the Cancer Pharmacy Team at Oxford University Hospitals NHS Foundation Trust. From being the sole full-time technician among three, the team has now grown to nearly 20 members.Throughout her tenure, Chandra has shaped technician roles and spearheaded the establishment of a new pharmacy service for cancer patients undergoing chemotherapy. Passionate about fostering learning and development, she aims to create a happier and healthier workplace for all pharmacy technicians.

This episode features Bhavesh Shah, Chief Pharmacy Officer Specialty and Hematology Oncology Pharmacy at Boston Medical Center (BMC). Here, he discusses his experience staying with the same organization for over 2 decades, trends he is watching in the pharmacy space, health equity initiatives at BMC, and more.

On this week's episode of The PQI Podcast, we sit down with Makenna Smack, PharmD, BCOP, from MD Anderson, to discuss molecular testing and targeted treatment in colorectal cancer. Makenna obtained her bachelor's in biochemistry from Brigham Young University and Doctor of Pharmacy from Roseman University in South Jordan, Utah. After graduation, she completed her PGY1 pharmacy residency at Memorial Hermann Hospital System in Houston, Texas, and a PGY2 oncology residency at Boston Medical Center in Massachusetts.She is board-certified by the Board of Pharmacy Specialties in Oncology Pharmacy. Makenna currently works in the Gastrointestinal (GI) Medical Oncology Clinic at MD Anderson. In this role, she is part of the multidisciplinary team overseeing the care of patients with colon, rectal, hepatobiliary, neuroendocrine, pancreatic, hepatic, and upper GI cancers. Makenna is passionate about providing effective patient education, adverse event management, and supportive care for her oncology patients. Outside of work, Makenna enjoys the snowless winters in Houston, trying new restaurants, and going to the park with her husband and son.

In this latest episode of ASTCT Talks, Dr. Rebecca Gonzalez sits down with Dr. Katie Gatwood and Dr. Timothy Porter to kick off National Pharmacy Month by discussing the clinical implications of post-transplant cyclophosphamide (PTCy) use outside of the haploidentical setting. They delve into their respective cancer centers' primary donor sources for match unrelated donors and the breakdown of conditioning intensity within their hematologic patients. They delve into the future of PTCy discussing the potential for earlier de-escalation of immunosuppressants to limit drug-related toxicities and optimize patient outcomes as well as important supportive care considerations. Despite the exciting prospects, the need for robust prospective data before implementation is emphasized. About Dr. Rebecca Gonzalez Dr. Rebecca Gonzalez (@xnyerin) received her Doctor of Pharmacy degree from the University of Florida College of Pharmacy. She completed her PGY2 Oncology residency at West Virginia University in Morgantown, West Virginia. Following post-doctoral training, Dr. Gonzalez was a Hematology Clinical Pharmacist at the Roswell Park Cancer Institute prior to transitioning to Moffitt Cancer Center in 2015. She is Board Certified in Oncology Pharmacy and currently practices as a Clinical Pharmacist in Blood and Marrow Transplant/Cellular Immunotherapy at Moffitt in Tampa, Florida. She was a past chair of the ASTCT Pharmacy Program Planning Committee in 2021-2022 and has been involved in several ASTCT teaching activities since 2017. Her interests include survivorship, GVHD, supportive care and infectious disease complications related to transplant and immune cellular therapy. About Dr. Katie Gatwood Dr. Gatwood is a Board-Certified Oncology Pharmacist and Clinical Pharmacist Specialist specializing in Adult Stem Cell Transplant and Cellular Therapy at Vanderbilt University Medical Center. She holds a Doctor of Pharmacy degree from the University of Michigan and completed her residency training at the University of North Carolina Health Care. Dr. Gatwood is the chair-elect of the ASTCT Pharmacy SIG Sterring Committee. She was also awarded the 2021 ASTCT Pharmacy SIG New Practitioner Award and is passionate about clinical research and education, with a focus on VOD, CAR T-cell therapy, and oncology pharmacists' role in ambulatory care. About Dr. Timothy Porter Dr. Timothy Porter is a Board-Certified Oncology Pharmacist and practices as a Clinical Pharmacy Specialist in Blood and Marrow Transplantation and Cellular Immunotherapy at Moffitt Cancer Center in Tampa, FL. He earned a Doctor of Pharmacy degree from Duquesne University School of Pharmacy and then completed a PGY1 Pharmacy Residency at Allegheny General Hospital in Pittsburgh, PA, followed by a PGY2 Oncology Pharmacy Residency at The Johns Hopkins Hospital in Baltimore, MD. He then practiced as a Clinical Pharmacy Specialist in Blood and Marrow Transplantation and Cellular Therapy at The Johns Hopkins Hospital before transitioning to Moffitt Cancer Center in 2022. Dr. Porter is a member of the ASTCT Pharmacy SIG Education Committee and serves as the Journal Club Lead. His professional interests include management of infectious complications in immunocompromised patients, GVHD, CAR T-cell therapy, clinical research, and education.

On this week's episode of The PQI Podcast, we sit down with experienced oncology pharmacy technicians Janine Brodeur, CPhT, COPhT, Nora Hansen, CPhT, COPhT, and Taryn Newsome, CPhT!We discuss the vital role of oncology pharmacy technicians in patient care, the Oncology Pharmacy Technician Association (OPTA), and the value of OPTA's new oral oncology certification for technicians.More information on OPTA's certification can be found here.

Season 4 Episode 1- Personal Story and Cone Health Clinical Oncology Pharmacy Program with John Ingoglia This week we sit down with John Ingoglia, PharmD, BCOP, CPP to discuss his personal story and the Cone Health Clinical Oncology Pharmacy Program.  Dr. Ingoglia is the Clinical Pharmacy Coordinator for the oncology service line at Cone Health. He received his Clinical Pharmacist Practitioner license in April 2022 and currently runs the breast oncology pharmacy clinic in collaboration with the medical oncologists he supports. He received his Doctor of Pharmacy from Lake Erie College of Osteopathic Medicine School of Pharmacy in Bradenton, FL in 2016 and completed both his PGY-1 Pharmacy Practice Residency and PGY-2 Oncology Practice Residency at Moffitt Cancer Center. Dr. Ingoglia's professional interests include medical oncology, malignant hematology, and infectious diseases. Personally, he enjoys spending time with his wife, three daughters, and two dogs.

Season 3 Bonus Episode- The Elevated Role of the Oncology Pharmacy Technician, Amanda Skeen, CPhT This week we sit down with Amanda Skeen, CPhT to discuss her role as an oncology pharmacy technician, drug purchasing, and robotics. Amanda has worked as a certified pharmacy technician since 2009 and is currently the Oncology Purchasing Agent for the Cancer Center service line at Cone Health. She manages a multi-million-dollar pharmaceutical inventory, as well as leads their compliance initiatives and hazardous drug compounding robotics program. For more information on the Oncology Pharmacy Technician Association please email Taryn.Newsome@ncoda.org. 

Dr. Kelley Carlstrom (aka KelleyCPharmD) talks about her Enjoy Learning Oncology (ELO) Programs.  If you're an oncology pharmacist, you need to listen to this episode! My Back-to-School Series features interviews with 9 pharmacists who teach online courses. Since it's back-to-school time for my kids, I created a Back-to-School series for my podcast! Check out the series, and get inspired to either learn or create!   Thank you for listening to episode 171 of The Pharmacist's Voice ® Podcast! To read the full show notes, visit https://www.thepharmacistsvoice.com.  Click on the podcast tab, and search for episode 171. Bio: Dr. Kelley Carlstrom received her Doctor of Pharmacy from The University of Colorado in 2010 and completed 2 years of post-graduate residency training to specialize in oncology. She is a board-certified oncology pharmacist that has worked in a variety of traditional and non-traditional settings including at a large academic medical center, a small community hospital, as a consultant for a large electronic medical record implementation, and most recently in the healthcare technology industry helping to create digital products and services for oncology clinicians and patients. In 2019, Kelley founded KelleyCPharmD, an education company that supports pharmacists in developing their baseline oncology knowledge. She is passionate about decolonizing oncology pharmacy training and increasing accessibility and inclusion through her unique and innovative training programs. Links from this episode  Website https://www.kelleycpharmd.com ELO Blueprint Program ELO Collaborative Program ELO Certificate Program Kelley Carlstrom on LinkedIn Kelley Carlstrom on Instagram Kelley Carlstrom on Twitter BPS BCOP Exam https://www.bpsweb.org/bps-specialties/oncology-pharmacy/ 

Season 2, Episode 19 - Oncology Pharmacy TechniciansOn this week's episode of The PQI Podcast we welcome Vonda McClendon, CPhT and Rebecca Garland, RPhT to discuss their paths to becoming oncology pharmacy technicians, the aspects of their roles they most enjoy, how pharmacy technicians can make a difference in patient adherence, and the value in NCODA's Oncology Pharmacy Technician Association (OPTA).Vonda leads the STAR Compliance Retail Services team at Texas Oncology. Rebecca is the Pharmacy Adherence Manager at Florida Cancer Specialists & Reserach Institute - Rx To Go Pharmacy. Vonda and Rebecca are also active members of OPTA.Season 2, Episode 19 is now streaming on Apple Podcasts, Spotify or at the link below. For more information on OPTA contact Taryn.Newsome@ncoda.org.

Dr. Jenna Carmichael is a graduate of the University of Arizona, College of Pharmacy. She completed her PGY1 at the Sierra Nevada VA Health Care System in Reno, NV, and her PGY2 in Oncology Pharmacy at Geisinger Medical Center in Danville, PA. She spent 5 years working as a Clinical Oncology Pharmacist specializing in Oral Chemotherapy Medication Therapy Management for Geisinger Health Care System and over that time, grew the clinic to over 1000 patients. She also was the PGY2 Oncology Residency Program Director and a clinical researcher. As a high achiever, over time, Jenna became burnt out, unhappy in her career and life, and knew things needed to change. She was able to find herself again through personal discovery and holistic healing methods. Naturally, she wanted to share this knowledge with her patients but found that the traditional Western Medicine structure didn't allow for the combination of all of her knowledge. Dr. Carmichael now runs her own practice as a Holistic Oncology Pharmacist and Health Coach, Wobbly Arrow Wellness. She works virtually with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. ______ Connect with Jenna via: Website: www.wobblyarrowwellness.com Email: jenna@wobblyarrowwellness.com Facebook: https://www.facebook.com/wobblyarrowwellness Facebook Group: https://www.facebook.com/groups/beacancercontrarian Instagram: https://www.instagram.com/jenna_carmichael/ Linkedin: https://www.linkedin.com/in/jenna-carmichael-42267218/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Jenna Carmichael is a graduate of the University of Arizona, College of Pharmacy. She completed her PGY1 at the Sierra Nevada VA Health Care System in Reno, NV, and her PGY2 in Oncology Pharmacy at Geisinger Medical Center in Danville, PA. She spent 5 years working as a Clinical Oncology Pharmacist specializing in Oral Chemotherapy Medication Therapy Management for Geisinger Health Care System and over that time, grew the clinic to over 1000 patients. She also was the PGY2 Oncology Residency Program Director and a clinical researcher. As a high achiever, over time, Jenna became burnt out, unhappy in her career and life, and knew things needed to change. She was able to find herself again through personal discovery and holistic healing methods. Naturally, she wanted to share this knowledge with her patients but found that the traditional Western Medicine structure didn't allow for the combination of all of her knowledge. Dr. Carmichael now runs her own practice as a Holistic Oncology Pharmacist and Health Coach, Wobbly Arrow Wellness. She works virtually with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. ______ Connect with Jenna via: Website: www.wobblyarrowwellness.com Email: jenna@wobblyarrowwellness.com Facebook: https://www.facebook.com/wobblyarrowwellness Facebook Group: https://www.facebook.com/groups/beacancercontrarian Instagram: https://www.instagram.com/jenna_carmichael/ Linkedin: https://www.linkedin.com/in/jenna-carmichael-42267218/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Hi there! We will be releasing biweekly episodes on the Holistic Pharmacy Podcast from now on. Last time you met my new cohost Dr. Jenna Carmichael - and today I am airing an interview I conducted with her a little while back when preparing for this season. Dr. Jenna Carmichael is a graduate of the University of Arizona, College of Pharmacy. She completed her PGY1 at the Sierra Nevada VA Health Care System in Reno, NV, and her PGY2 in Oncology Pharmacy at Geisinger Medical Center in Danville, PA. She spent 5 years working as a Clinical Oncology Pharmacist specializing in Oral Chemotherapy Medication Therapy Management for Geisinger Health Care System and over that time, grew the clinic to over 1000 patients. She also was the PGY2 Oncology Residency Program Director and a clinical researcher. As a high achiever, over time, Jenna became burnt out, unhappy in her career and life, and knew things needed to change. She was able to find herself again through personal discovery and holistic healing methods. Naturally, she wanted to share this knowledge with her patients but found that the traditional Western Medicine structure didn't allow for the combination of all of her knowledge. Dr. Carmichael now runs her own practice as a Holistic Oncology Pharmacist and Health Coach, Wobbly Arrow Wellness. She works virtually with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. Connect with Jenna via: Website: www.wobblyarrowwellness.com Email: jenna@wobblyarrowwellness.com Facebook: https://www.facebook.com/wobblyarrowwellness Facebook Group: https://www.facebook.com/groups/beacancercontrarian Instagram: https://www.instagram.com/jenna_carmichael/ Linkedin: https://www.linkedin.com/in/jenna-carmichael-42267218/ For more amazing content, visit us at https://drmarinabuksov.com. Music: https://www.purple-planet.com.

In the latest episode of our Insight to Access podcast series, we sit down with Julie Kennerly-Shah, Assistant Director of Pharmacy at the James Cancer Center, to get her perspective and personal experience on: Key considerations in the evaluation of providing home infusion services Benefits and challenges of shifting infusions to the home setting Why some systems are piloting these services while others are waiting on the sidelines

Despite some biosimilars, including those for filgrastim, trastuzumab, and bevacizumab, achieving a greater US market share than their originators, other biosimilar categories, such as pegfilgrastim and infliximab, are still trailing behind. Some biosimilar companies are becoming more savvy, developing new ways to make a bigger statement in the market. We sat down with Kirollos Hanna, PharmD, the manager of Oncology Pharmacy at the University of Minnesota Medical Center, an associate editor for the Journal of the Advanced Practitioner in Oncology, and an assistant professor at the Mayo Clinic School of Medicine, to discuss what tactics biosimilar companies are using to better compete alongside originator manufacturers.

Oncology Pharmacy Services with guests Nancy Beaulieu and Brenda Sepulveda June 20, 2021 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Oncology Pharmacy Services with guests Nancy Beaulieu and Brenda Sepulveda June 20, 2021 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Oncology Pharmacy Services with guests Nancy Beaulieu and Brenda Sepulveda June 20, 2021 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

262. Oncology Pharmacy Informatics feat. Dr. Nicholas Bacon Intended Audience: Everyone On today's episode, we delve into the niche world of oncology pharmacy informatics. Dr. Nicholas Bacon shares his experience in how he got into the oncology space and subsequently into the oncology informatics space with his skillset. He discusses what is needed to find your niche and also briefly talks about how it's so necessary to have a pharmacist in the oncology informatics space to serve as a liaison between the clinical and technical sides. You can reach out to Dr. Bacon at https://www.linkedin.com/in/nrbaconpharmd/ ========== Interested in learning more about pharmacy informatics? Check out the FREE Introduction to Pharmacy Informatics course at www.pharmacyinformaticsacademy.com ! New to LinkedIn and not sure where to start? Download my free ebook, "Professional Networking Unlocked", at https://www.tonydaopharmd.com/ebook Follow us on social media! Twitter: @pharmacyitme Instagram: @pharmacyinformatics LinkedIn: https://www.linkedin.com/company/pharmacyitme/ Website: Pharmacy IT & Me Email: tony@pharmacyitme.com Follow Tony's personal Twitter account at @tonydaopharmd Network with other pharmacists at Pharmacists Connect!http://pharmacistsconnect.com For more information on pharmacy informatics, check out some of the following useful links: ASHP's Section of Pharmacy Informatics and Technology: https://www.ashp.org/Pharmacy-Informaticist/Section-of-Pharmacy-Informatics-and-Technology/ HIMSS Pharmacy Informatics Community: https://www.himss.org/library/pharmacy-informatics Disclaimer: Views expressed are my own and do not reflect thoughts and opinions of any entity with which I have been, am now, or will be affiliated.

You’re a pharmacist, so you just hand out boxes of drugs, right? Very wrong!As pharmacist we can also play a key role in the complexity of prescribing medication regimens as essential members of the interdisciplinary team, in order to optimize the benefits of drug therapies and ensure patient safety.In this week’s episode we dive deeper into the scope of hospital pharmacy, more specifically; Oncology Pharmacy.We catch up with Mikie Hughes, who shares her PharmaHack jounery, where she started in Marine biology. Yes! Marine Biology, so make sure you listen till the end!Mikie shares how her curiosity and early career HACKS has led her to where she is today a Grade 2 Clinical Oncology Hospital Pharmacist.Topics covered:What is Oncology PharmacyRoles and opportunities of Oncology pharmacistOncology pharmacist vs Clinical trial PharmacistCareer trajectory in Oncology PharmacyPractical tips and strategies to help you HACK a career hospital (oncology) PharmacyEarly career hacks for pharmacy students interested in hospital (oncology) PharmacyIf you’re a student or pharmacist looking to begin hacking your career, but not sure if your resume is holding you back from the interviews you deserve? We’ve teamed up with our friend at PharmacyConnect and put together a guide: 7 WARNING signs your resume sucks! Including 3 ESSENTIAL tips to writing an impressive application that can land you the Job.If you're serious about hacking your career, then download the guide and begin hacking your way to a fulfilling career TODAY!DON’T FORGET TO SUBSCRIBE! Follow us on:Instagram: @Pharmahack_career Facebook: PharmaHack: CareerTwitter: @HackPharma LinkedIn: PharmaHack: Career Podcast Website: pharmahack.org

This year, the Centers for Medicare & Medicaid Services reported that of the top ten discarded drugs reimbursed by Medicare Part B in 2018, six were cancer medications, totaling 330 million dollars. On this episode of CANCER BUZZ, learn about the ways cancer programs are working to reduce drug waste and curb the rising cost of cancer care.Guest: Anthony Boyd, PharmD, BCPS, Pharmacy Manager, Oncology, Cleveland ClinicRelated Content:ACCC Oncology Pharmacy Education NetworkWaste Not, Want NotUNC Combats Rising Drug Prices by Reducing Expensive WasteThe Evolution of Oncology Pharmacy (podcast)Facilitating Access to Cancer ImmunotherapiesPart B Discarded Drug Units Report, Centers for Medicare & Medicaid ServicesThe views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

Cancer centers across the United States had to be creative in meeting demand for medications as drug shortages spiked in different regions during the COVID-19 pandemic. Moderator Niesha Griffith, RPh, MS, FASHP, Chief Pharmacy Officer, Columbus, OH discusses some of the lessons learned and the unintended consequences that arose when working with vendors during the pandemic. She is joined by Bhavesh Shah, RPh, BCOP, Director of Specialty and Hematology/Oncology Pharmacy, Boston Medical Center, and Scott Freeswick, MS, PharmD, Vice President and Chief Pharmacy Officer, Memorial Sloan Kettering Cancer for the Deeper Dive.The webcast on which this podcast episode is based was originally presented on July 21, 2020. The replay can be accessed here: http://www.valuebasedcancer.com/avbcc/covid-19-webcast-series/webcast-replays/2677-july-21-2020-oncology-pharmacy-update-covid-19-recovery-the-road-ahead.

On this episode of CANCER BUZZ, learn more about the role that oncology pharmacists play in cancer care and how that role is changing in the face of new therapies and the advent of value-based health.Oncology pharmacy has undergone a rapid transformation in recent years. On this episode of CANCER BUZZ, learn more about the role that oncology pharmacists play in cancer care and how that role is changing in the face of new therapies and the advent of value-based health. Discover how the University of North Carolina Hospital’s Department of Pharmacy developed a closed-loop, pharmacy-managed, pre-certification and denials management program to avoid passing surprise bills to patients and ensure financial stability for the cancer program.Guests:Ali McBride, PharmD, MS, BCOP, Clinical Coordinator of Hematology/Oncology, University of Arizona Cancer Center, Department of Pharmacy; 2019-2020 ACCC PresidentSuzanne Francart, PharmD, BCPS, Assistant Director of Pharmacy, The University of North Carolina Hospitals Relevant Content:Oncology Pharmacy Education Network (OPEN)"Facilitating Access to Cancer Immunotherapies," OPEN Insights"ACCC Celebrates American Pharmacists Month," by Ali McBride, PharmD, MS, BCOP“The Oncology Pharmacist’s Role in Immuno-Oncology,” a Q&A with Ali McBride“Proactive Precertification Pays Off,” by Suzanne Francart, PharmD, BCPSUNC Hospital, Department of Pharmacy, 2019 ACCC Innovator Award recipient2019 ACCC Patient Assistance & Reimbursement Guide The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

Had a blast on this one. Hope you enjoy the throwback. On this episode we talk about the ins and outs of being an Oncology Pharmacist. Dr. Orozco shares her experience doing a PGY2 and gives some advice to anyone interested in specializing in her amazing field. Email Dr. Orozco: Orozcoj@mskcc.org Links Referenced: https://www.asco.org https://www.nccn.org/professionals/physician_gls/default.aspx american cancer society Music 1: https://soundcloud.com/dixxy-2/cool-nights Music 2: https://soundcloud.com/aka-dj-quads/saturdays Music 3: https://soundcloud.com/aka-dj-quads/gonna-miss-u Like us on Facebook: https://www.facebook.com/rxradio.fm/ Check out our memes on Instagram: instagram.com/rxradio.fm Follow us on Twitter: twitter.com/rxradiofm Host: Dr. Richard Waithe www.twitter.com/thepharmacydude www.facebook.com/pharmacydude www.instagram.com/richiewaithe

We open up the Ask #OncoPharm inbox to answer a listener question - What advice do you have before starting my PGY2 Oncology Pharmacy Residency?

The Landmarks in Oncology Pharmacy series returns to discuss the International Randomized Study of Interferon vs. STI571 (imatinib) aka IRIS.

The Landmarks in Oncology Pharmacy series returns with a discussion of MOSAIC: FOLFOX adjuvant chemotherapy for stage ii & STAGE III colon cancer.

The Landmarks in Oncology Pharmacy series returns with the P1 study. We review this landmark paper paving the way for breast cancer risk reduction (or chemoprevention) and discuss the mark or lack thereof (frown emoji) it has made in clinical practice.

The Landmarks in Oncology Pharmacy series returns with a review of 2 ondansetron studies from 1990, published simultaneously in NEJM.

The Foundations in Oncology Pharmacy continues with vincristine. Its origin, unique toxicity profile, and clinical use is discussed. Periwinkle!

The Landmarks series continues with Bonadonna's classic adjuvant CMF regimen in breast cancer in a pre-tamoxifen & pre-ER/PR testing era. Discussion points include number needed to treat (NNT) to prevent recurrence and how chlorambucil was considered for the 'C' in CMF.

Overview of doxorubicin from its Italian origins to its Red Devil alias. Uses and toxicities also discussed, of course.

New Drug Approval: Lutetium-177-dotatate is discussed as well as updates to indications for denosumab (m. myeloma), afatinib, & olaparib.

On this episode we talk about the ins and outs of being an Oncology Pharmacist. Dr. Orozco shares her experience doing a PGY2 and gives some advice to anyone interested in specializing in her amazing field. Email Dr. Orozco: Orozcoj@mskcc.org Links Referenced: https://www.asco.org https://www.nccn.org/professionals/physician_gls/default.aspx american cancer society Music 1: https://soundcloud.com/dixxy-2/cool-nights Music 2: https://soundcloud.com/aka-dj-quads/saturdays Music 3: https://soundcloud.com/aka-dj-quads/gonna-miss-u Like us on Facebook: https://www.facebook.com/rxradio.fm/ Check out our memes on Instagram: instagram.com/rxradio.fm Follow us on Twitter: twitter.com/rxradiofm Host: Dr. Richard Waithe www.twitter.com/thepharmacydude www.facebook.com/pharmacydude www.instagram.com/richiewaithe

The Landmarks series continues with DeVita's original MOPP (Hodgkin's Disease) publication from 1970. Discussion points include WBC monitoring, why cyclophosphamide isn't included, and wigs.

The Foundations in Oncology Pharmacy series begins with the penicillin of oncology: cisplatin. Discussion of its history, current uses, & toxicities. Perfect for those new to oncology pharmacy.

Review of recent FDA action re: oncology pharmacy including review of the APHINITIY trial and pertuzumab's subsequent approval in the adjuvant setting. Also, the nilotinib label change allowing for discontinuation in CML patients is discussed.

In the 1st of the Landmarks series, we look back at a pivotal article published in Blood in 1958 on the treatment of acute leukemia.

Jim Siderov is the senior Oncology Pharmacist at Austin Health. He is also an Australian Advanced Practice Pharmacist and is US Board Certified in Oncology Pharmacy.    We speak to Jim about:  Checkpoint inhibitors: their mechanism and role in oncology  Autoimmune toxicities and how they are managed clinically  Emerging evidence and future potential uses for these agents

Time to Talk CINV